Lupus nephritis - who class IV
Clinical trials for Lupus nephritis - who class IV explained in plain language.
Never miss a new study
Get alerted when new Lupus nephritis - who class IV trials appear
Sign up with your email to follow new studies for Lupus nephritis - who class IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on lupus kidney disease
Disease control Recruiting nowThis phase 2 trial is testing a new treatment called FT819 for people with lupus nephritis, a serious kidney complication of lupus. FT819 is made from donor immune cells that are engineered to target and destroy faulty B cells. The study will enroll 53 participants and aims to se…
Matched conditions: LUPUS NEPHRITIS - WHO CLASS IV
Phase 2 • Sponsor: Fate Therapeutics • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
New lupus pill ONT01 enters human safety trials
Disease control Recruiting nowThis early-phase study tests whether a new drug called ONT01 is safe for people with lupus nephritis or systemic lupus erythematosus (SLE). About 61 participants will receive ONT01 alongside their usual lupus medications. The goal is to find the highest safe dose and see if it im…
Matched conditions: LUPUS NEPHRITIS - WHO CLASS IV
Early phase 1 • Sponsor: Hospital for Special Surgery, New York • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC